{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:28:55Z","timestamp":1792801735773,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T00:00:00Z","timestamp":1554163200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T00:00:00Z","timestamp":1554163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K24AR06029"],"award-info":[{"award-number":["K24AR06029"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["T32AR050958"],"award-info":[{"award-number":["T32AR050958"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Center for Advancing Clinical Sciences","award":["UL1TR001450, KL2TR001452"],"award-info":[{"award-number":["UL1TR001450, KL2TR001452"]}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"crossref","award":["P30AR072582"],"award-info":[{"award-number":["P30AR072582"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"crossref"}]},{"name":"SmartState and Kitty Trask Holt Endowment","award":["none"],"award-info":[{"award-number":["none"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13075-019-1870-6","type":"journal-article","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T08:03:05Z","timestamp":1554192185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Estradiol levels are elevated in older men with diffuse cutaneous SSc and are associated with decreased survival"],"prefix":"10.1186","volume":"21","author":[{"given":"DeAnna","family":"Baker Frost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Peoples","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Fike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Laffoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Thomas A.","family":"Medsger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Feghali-Bostwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,2]]},"reference":[{"key":"1870_CR1","volume-title":"Systemic sclerosis and scleroderma variants: clinical aspects","author":"R Silver","year":"2005","unstructured":"Silver R, Medsger TA Jr, Bolster MB. Systemic sclerosis and scleroderma variants: clinical aspects. In: ML KWJ, editor. . Philadelphia: Lippincott, Williams & Wilkins; 2005."},{"issue":"Suppl 3","key":"1870_CR2","first-page":"S135","volume":"7","author":"EC LeRoy","year":"1989","unstructured":"LeRoy EC. The pathogenesis of systemic sclerosis. Clin Exp Rheumatol. 1989;7(Suppl 3):S135\u20137.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"1870_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.semarthrit.2008.06.002","volume":"39","author":"FF Al-Dhaher","year":"2010","unstructured":"Al-Dhaher FF, Pope JE, Ouimet JM. Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin Arthritis Rheum. 2010;39(4):269\u201377.","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"1870_CR4","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1007\/s10067-018-4291-z","volume":"37","author":"X Li","year":"2018","unstructured":"Li X, Qian YQ, Liu N, Mu R, Zuo Y, Wang GC, et al. Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study. Clin Rheumatol. 2018;37(11):3051\u20136.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"1870_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00393-018-0492-8","volume":"78","author":"YH Lee","year":"2019","unstructured":"Lee YH. Overall and sex- and disease subtype-specific mortality in patients with systemic sclerosis: an updated meta-analysis. Z Rheumatol. 2019;78(2):195\u2013201.","journal-title":"Z Rheumatol"},{"issue":"2","key":"1870_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1365-2133.2011.10624.x","volume":"166","author":"H Muller","year":"2012","unstructured":"Muller H, Rehberger P, Gunther C, Schmitt J. Determinants of disability, quality of life and depression in dermatological patients with systemic scleroderma. Br J Dermatol. 2012;166(2):343\u201353.","journal-title":"Br J Dermatol"},{"issue":"2","key":"1870_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5301\/jsrd.5000198","volume":"1","author":"C Peoples","year":"2016","unstructured":"Peoples C, Medsger TA Jr, Lucas M, Rosario BL, Feghali-Bostwick CA. Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes. J Scleroderma Relat Disord. 2016;1(2):177\u2013240.","journal-title":"J Scleroderma Relat Disord"},{"issue":"7","key":"1870_CR8","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1136\/ard.2006.066068","volume":"66","author":"VD Steen","year":"2007","unstructured":"Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis. 2007;66(7):940\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1870_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.molmed.2012.12.007","volume":"19","author":"J Cui","year":"2013","unstructured":"Cui J, Shen Y, Li R. Estrogen synthesis and signaling pathways during aging: from periphery to brain. Trends Mol Med. 2013;19(3):197\u2013209.","journal-title":"Trends Mol Med"},{"issue":"2","key":"1870_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/tam.5.2.98.102","volume":"5","author":"A Vermeulen","year":"2002","unstructured":"Vermeulen A, Kaufman JM, Goemaere S, van Pottelberg I. Estradiol in elderly men. Aging Male. 2002;5(2):98\u2013102.","journal-title":"Aging Male"},{"issue":"1","key":"1870_CR11","doi-asserted-by":"publisher","first-page":"R10","DOI":"10.1186\/ar4140","volume":"15","author":"K Aida-Yasuoka","year":"2013","unstructured":"Aida-Yasuoka K, Peoples C, Yasuoka H, Hershberger P, Thiel K, Cauley JA, et al. Estradiol promotes the development of a fibrotic phenotype and is increased in the serum of patients with systemic sclerosis. Arthritis Res Ther. 2013;15(1):R10.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"1870_CR12","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/rheumatology\/keu432","volume":"54","author":"D Perkovic","year":"2015","unstructured":"Perkovic D, Martinovic Kaliterna D, Jurisic Z, Lalovac M, Radic M. Androgens in post-menopausal patients with systemic sclerosis. Rheumatology (Oxford). 2015;54(4):744\u20136.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"1870_CR13","first-page":"1892","volume":"20","author":"PJ Clements","year":"1993","unstructured":"Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol. 1993;20(11):1892\u20136.","journal-title":"J Rheumatol"},{"issue":"1","key":"1870_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1136\/ard.2009.127621","volume":"70","author":"RT Domsic","year":"2011","unstructured":"Domsic RT, Rodriguez-Reyna T, Lucas M, Fertig N, Medsger TA Jr. Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma. Ann Rheum Dis. 2011;70(1):104\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1870_CR15","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1002\/art.24586","volume":"61","author":"N Fertig","year":"2009","unstructured":"Fertig N, Domsic RT, Rodriguez-Reyna T, Kuwana M, Lucas M, Medsger TA Jr, et al. Anti-U11\/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis. Arthritis Rheum. 2009;61(7):958\u201365.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1870_CR16","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"PM Grambsch","year":"1994","unstructured":"Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81(3):515\u201326.","journal-title":"Biometrika."},{"issue":"4","key":"1870_CR17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/annrheumdis-2017-211912","volume":"77","author":"AL Herrick","year":"2018","unstructured":"Herrick AL, Peytrignet S, Lunt M, Pan X, Hesselstrand R, Mouthon L, et al. Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study. Ann Rheum Dis. 2018;77(4):563\u201370.","journal-title":"Ann Rheum Dis"},{"key":"1870_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1749-6632.2009.05296.x","volume":"1193","author":"S Soldano","year":"2010","unstructured":"Soldano S, Montagna P, Brizzolara R, Sulli A, Parodi A, Seriolo B, et al. Effects of estrogens on extracellular matrix synthesis in cultures of human normal and scleroderma skin fibroblasts. Ann N Y Acad Sci. 2010;1193:25\u20139.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"1870_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5301\/jsrd.5000238","volume":"2","author":"SM Garrett","year":"2017","unstructured":"Garrett SM, Frost DB, Feghali-Bostwick C. The mighty fibroblast and its utility in scleroderma research. J Scleroderma Relat Disord. 2017;2(2):69\u2013134.","journal-title":"J Scleroderma Relat Disord"},{"issue":"2","key":"1870_CR20","first-page":"241","volume":"18","author":"WD Xu","year":"1991","unstructured":"Xu WD, Leroy EC, Smith EA. Fibronectin release by systemic sclerosis and normal dermal fibroblasts in response to TGF-beta. J Rheumatol. 1991;18(2):241\u20136.","journal-title":"J Rheumatol"},{"issue":"1","key":"1870_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0006-291X(05)81456-1","volume":"187","author":"K Kikuchi","year":"1992","unstructured":"Kikuchi K, Hartl CW, Smith EA, LeRoy EC, Trojanowska M. Direct demonstration of transcriptional activation of collagen gene expression in systemic sclerosis fibroblasts: insensitivity to TGF beta 1 stimulation. Biochem Biophys Res Commun. 1992;187(1):45\u201350.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"1870_CR22","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jaad.2004.08.039","volume":"53","author":"G Hall","year":"2005","unstructured":"Hall G, Phillips TJ. Estrogen and skin: the effects of estrogen, menopause, and hormone replacement therapy on the skin. J Am Acad Dermatol. 2005;53(4):555\u201368 quiz 69-72.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1870_CR23","first-page":"273","volume":"45","author":"D Kalogirou","year":"2000","unstructured":"Kalogirou D, Aroni K, Kalogirou O, Antoniou G, Botsis D, Kontoravdis A. Histological changes induced by tibolone and estrogen\/glucocorticoid on aging skin. Int J Fertil Womens Med. 2000;45(4):273\u20138.","journal-title":"Int J Fertil Womens Med"},{"issue":"2","key":"1870_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0378-5122(92)90245-Y","volume":"15","author":"C Castelo-Branco","year":"1992","unstructured":"Castelo-Branco C, Duran M, Gonzalez-Merlo J. Skin collagen changes related to age and hormone replacement therapy. Maturitas. 1992;15(2):113\u20139.","journal-title":"Maturitas"},{"issue":"2","key":"1870_CR25","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/S0002-9378(94)70242-X","volume":"170","author":"R Maheux","year":"1994","unstructured":"Maheux R, Naud F, Rioux M, Grenier R, Lemay A, Guy J, et al. A randomized, double-blind, placebo-controlled study on the effect of conjugated estrogens on skin thickness. Am J Obstet Gynecol. 1994;170(2):642\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"1870_CR26","unstructured":"Meschia M. BF, Amicarelli F., Barbacini P., Monza G.C., Crosignani P.G. Transdermal hormone replacement therapy and skin in postmenopausal women, a placebo controlled study. Menopause. 1994;1:79\u201382."},{"issue":"3","key":"1870_CR27","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1471-0528.1985.tb01091.x","volume":"92","author":"M Brincat","year":"1985","unstructured":"Brincat M, Moniz CJ, Studd JW, Darby A, Magos A, Emburey G, et al. Long-term effects of the menopause and sex hormones on skin thickness. Br J Obstet Gynaecol. 1985;92(3):256\u20139.","journal-title":"Br J Obstet Gynaecol"},{"key":"1870_CR28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1196\/annals.1351.023","volume":"1069","author":"L Mirone","year":"2006","unstructured":"Mirone L, Barini A. Androgen and prolactin (Prl) levels in systemic sclerosis (SSc): relationship to disease severity. Ann N Y Acad Sci. 2006;1069:257\u201362.","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"1870_CR29","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/BF00376615","volume":"283","author":"GB Jemec","year":"1991","unstructured":"Jemec GB, Sindrup JH. Circulating androgens in male patients suffering from systemic scleroderma. Arch Dermatol Res. 1991;283(5):289\u201391.","journal-title":"Arch Dermatol Res"},{"issue":"10","key":"1870_CR30","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.7326\/0003-4819-119-10-199311150-00007","volume":"119","author":"Y Okano","year":"1993","unstructured":"Okano Y, Steen VD, Medsger TA Jr. Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med. 1993;119(10):1005\u201313.","journal-title":"Ann Intern Med"},{"issue":"10","key":"1870_CR31","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s10067-011-1751-0","volume":"30","author":"ME Krzyszczak","year":"2011","unstructured":"Krzyszczak ME, Li Y, Ross SJ, Ceribelli A, Chan EK, Bubb MR, et al. Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies. Clin Rheumatol. 2011;30(10):1333\u20139.","journal-title":"Clin Rheumatol"},{"issue":"Suppl 106(4)","key":"1870_CR32","first-page":"89","volume":"35","author":"M Freire","year":"2017","unstructured":"Freire M, Rivera A, Sopena B, Tolosa Vilella C, Guillen-Del Castillo A, Colunga Arguelles D, et al. Clinical and epidemiological differences between men and women with systemic sclerosis: a study in a Spanish systemic sclerosis cohort and literature review. Clin Exp Rheumatol. 2017;35(Suppl 106(4)):89\u201397.","journal-title":"Clin Exp Rheumatol"},{"issue":"18","key":"1870_CR33","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1001\/jama.2009.639","volume":"301","author":"EA Jankowska","year":"2009","unstructured":"Jankowska EA, Rozentryt P, Ponikowska B, Hartmann O, Kustrzycka-Kratochwil D, Reczuch K, et al. Circulating estradiol and mortality in men with systolic chronic heart failure. JAMA. 2009;301(18):1892\u2013901.","journal-title":"JAMA"},{"issue":"6","key":"1870_CR34","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/rheumatology\/kew488","volume":"56","author":"LA Bissell","year":"2017","unstructured":"Bissell LA, Md Yusof MY, Buch MH. Primary myocardial disease in scleroderma-a comprehensive review of the literature to inform the UK Systemic Sclerosis Study Group cardiac working group. Rheumatol (Oxford). 2017;56(6):882\u201395.","journal-title":"Rheumatol (Oxford)"},{"issue":"1","key":"1870_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00296-015-3382-2","volume":"37","author":"A Fernandez-Codina","year":"2017","unstructured":"Fernandez-Codina A, Simeon-Aznar CP, Pinal-Fernandez I, Rodriguez-Palomares J, Pizzi MN, Hidalgo CE, et al. Cardiac involvement in systemic sclerosis: differences between clinical subsets and influence on survival. Rheumatol Int. 2017;37(1):75\u201384.","journal-title":"Rheumatol Int"},{"issue":"5","key":"1870_CR36","first-page":"1004","volume":"33","author":"K Scalapino","year":"2006","unstructured":"Scalapino K, Arkachaisri T, Lucas M, Fertig N, Helfrich DJ, Londino AV Jr, et al. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. J Rheumatol. 2006;33(5):1004\u201313.","journal-title":"J Rheumatol"},{"issue":"5","key":"1870_CR37","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1445-5994.2010.02281.x","volume":"41","author":"P Hissaria","year":"2011","unstructured":"Hissaria P, Lester S, Hakendorf P, Woodman R, Patterson K, Hill C, et al. Survival in scleroderma: results from the population-based South Australian Register. Intern Med J. 2011;41(5):381\u201390.","journal-title":"Intern Med J"},{"issue":"1","key":"1870_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/annrheumdis-2014-206386","volume":"75","author":"M Elhai","year":"2016","unstructured":"Elhai M, Avouac J, Walker UA, Matucci-Cerinic M, Riemekasten G, Airo P, et al. A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study. Ann Rheum Dis. 2016;75(1):163\u20139.","journal-title":"Ann Rheum Dis"},{"key":"1870_CR39","doi-asserted-by":"crossref","unstructured":"Chen X, Austin ED, Talati M, Fessel JP, Farber-Eger EH, Brittain EL, et al. Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects. Eur Respir J. 2017;50(2):1602337. \n                    https:\/\/erj.ersjournals.com\/content\/50\/2\/1602337\n                    \n                  .","DOI":"10.1183\/13993003.02337-2016"},{"issue":"10","key":"1870_CR40","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1002\/art.24859","volume":"60","author":"M Schmidt","year":"2009","unstructured":"Schmidt M, Hartung R, Capellino S, Cutolo M, Pfeifer-Leeg A, Straub RH. Estrone\/17beta-estradiol conversion to, and tumor necrosis factor inhibition by, estrogen metabolites in synovial cells of patients with rheumatoid arthritis and patients with osteoarthritis. Arthritis Rheum. 2009;60(10):2913\u201322.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1870_CR41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.autrev.2003.08.003","volume":"3","author":"M Cutolo","year":"2004","unstructured":"Cutolo M, Villaggio B, Seriolo B, Montagna P, Capellino S, Straub RH, et al. Synovial fluid estrogens in rheumatoid arthritis. Autoimmun Rev. 2004;3(3):193\u20138.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"1870_CR42","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1177\/096120339200100312","volume":"1","author":"M Folomeev","year":"1992","unstructured":"Folomeev M, Dougados M, Beaune J, Kouyoumdjian JC, Nahoul K, Amor B, et al. Plasma sex hormones and aromatase activity in tissues of patients with systemic lupus erythematosus. Lupus. 1992;1(3):191\u20135.","journal-title":"Lupus"},{"issue":"4","key":"1870_CR43","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/art.22510","volume":"56","author":"KH Costenbader","year":"2007","unstructured":"Costenbader KH, Feskanich D, Stampfer MJ, Karlson EW. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum. 2007;56(4):1251\u201362.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1870_CR44","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/art.33400","volume":"64","author":"T Colasanti","year":"2012","unstructured":"Colasanti T, Maselli A, Conti F, Sanchez M, Alessandri C, Barbati C, et al. Autoantibodies to estrogen receptor alpha interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus. Arthritis Rheum. 2012;64(3):778\u201387.","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1870-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-019-1870-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1870-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T14:00:14Z","timestamp":1589551214000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-019-1870-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,2]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1870"],"URL":"https:\/\/doi.org\/10.1186\/s13075-019-1870-6","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,2]]},"assertion":[{"value":"23 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was granted an exemption status from the University of Pittsburgh internal review board (IRB).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"85"}}